Answers are grounded in this paper and cite their sources.
Background: Paediatric Emergency Departments (EDs) face sustained operational pressure from seasonal infections and high volume of febrile presentations. These pressures coupled with the risk of missed serious bacterial infections and rising antimicrobial resistance (AMR) highlight the need for rapid, accurate diagnostic tools. Despite validation and the potential to support timely decision making, MeMed bacterial-viral (MMBV) point of care tests (POCT) are not routinely used in paediatric EDs in the NHS. Determinants of implementing rapid bacterial–viral point-of-care testing within NHS paediatric Emergency Departments are examined in this study. Methods: A new MMBV testing pathway was co-designed, implemented, and evaluated across three paediatric EDs in England (Alder Hey Children’s Hospital, Liverpool; Great North Children’s Hospital, Newcastle; and St Mary’s Hospital, London). A qualitative process evaluation (n=17 semi-structured interviews with clinical staff) was conducted alongside an interventional study. Interview transcripts were analysed using hybrid deductive–inductive coding structured by Proctor’s implementation outcomes and the Consolidated Framework for Implementation Research (CFIR). Results: Overall acceptability of MMBV testing was high. When asked about test suitability for managing undifferentiated febrile presentations, 11/17 participants responded “yes,” 3/17 “yes with conditions,” and 3/17 “no.” Penetration, fidelity, and feasibility were strongly associated with leadership engagement and governance structures. Appropriateness and opportunity cost were viewed favourably when testing targeted intermediate-risk (amber, NICE traffic-light system) children and supplemented clinical judgement, particularly amongst less experienced clinicians. Participants emphasised the importance of clear communication and safeguards to manage risks associated with reduced observation time. The MMBV host-protein assay was selected due to its diagnostic performance and 15-minute turnaround; however, strong preference was expressed for capillary sampling over the currently available venous sampling. Conclusions: Rapid bacterial-viral point of care testing may support decision making for intermediate-risk febrile children in paediatric EDs, but routine NHS adoption requires targeted use within a governed pathway, sustained POCT governance and clinical leadership, training resilient to workforce rotation, and operational and digital integration to minimise burden and risk. These findings provide service-relevant guidance for Trusts and commissioners considering adoption or scale-up.
No takes yet. Share an insight, caveat, or question.
Boland¹ et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: